Senti Biosciences, Inc.SNTINASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank32
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Latest
0.00%
↓ 100% vs avg
Percentile
P32
Within normal range
Average
21.98%
Historical baseline
PeriodValue
Q3 20250.00%
Q2 20250.00%
Q1 20250.00%
Q4 20240.00%
Q3 20240.00%
Q2 20240.00%
Q1 20240.00%
Q4 2023-100.00%
Q3 2023-72.79%
Q2 2023-27.14%
Q1 2023773.30%
Q4 2022-112.60%
Q3 202236.82%
Q2 20220.36%
Q1 202239.22%
Q4 2021-14.36%
Q3 202116.77%
Q2 20210.00%
Q1 2021-100.00%
Q4 20200.00%